Yuki Kageyama to Antineoplastic Combined Chemotherapy Protocols
This is a "connection" page, showing publications Yuki Kageyama has written about Antineoplastic Combined Chemotherapy Protocols.
Connection Strength
1.400
-
Clinical outcomes of nivolumab plus ipilimumab in patients with metastatic non-clear cell renal cell carcinoma: Real-world data from a Japanese multicenter retrospective study. Int J Urol. 2023 09; 30(9):714-721.
Score: 0.515
-
[Neoadjuvant chemotherapy for invasive bladder cancer]. Gan To Kagaku Ryoho. 2001 Nov; 28(12):1838-44.
Score: 0.119
-
Randomized Study of Postoperative Single Intravesical Instillation With Pirarubicin and Mitomycin C for Low-risk Bladder Cancer. Anticancer Res. 2020 Sep; 40(9):5295-5299.
Score: 0.110
-
Successful treatment of primary bone marrow Hodgkin lymphoma with brentuximab vedotin: a case report and review of the literature. J Med Case Rep. 2018 May 30; 12(1):151.
Score: 0.094
-
[Development of syndrome of inappropriate secretion of ADH and reversible posterior leukoencephalopathy during initial rituximab-CHOP therapy in a patient with diffuse large B-cell lymphoma]. Rinsho Ketsueki. 2013 Mar; 54(3):269-72.
Score: 0.065
-
[Result of treatment for advanced germ cell tumor in the last decade]. Nihon Hinyokika Gakkai Zasshi. 2010 Mar; 101(3):539-46.
Score: 0.053
-
[Bladder preservation by chemoradiotherapy in combination with radical TUR-Bt in muscle invasive bladder cancer]. Nihon Hinyokika Gakkai Zasshi. 2007 Sep; 98(6):752-6.
Score: 0.045
-
Incorporation of TIP (paclitaxel, ifosfamide, cisplatin) into first-line therapy for intermediate to poor risk testicular germ cell tumors with unfavorable marker decline after initial two cycles chemotherapy: a report of three cases. Int J Urol. 2007 May; 14(5):455-7.
Score: 0.044
-
Deferred combined androgen blockade therapy using bicalutamide in patients with hormone-refractory prostate cancer during androgen deprivation monotherapy. BJU Int. 2006 Jun; 97(6):1184-9.
Score: 0.041
-
[A case of secondary malignant lymphoma of the urinary bladder]. Hinyokika Kiyo. 2006 Apr; 52(4):285-7.
Score: 0.040
-
Efficacy and Safety of Bladder Preservation Therapy in Combination with Atezolizumab and Radiation Therapy (BPT-ART) for Invasive Bladder Cancer: Interim Analysis from a Multicenter, Open-label, Prospective Phase 2 Trial. Int J Radiat Oncol Biol Phys. 2023 11 01; 117(3):644-651.
Score: 0.033
-
TNP-470 combined with nicardipine suppresses in vivo growth of PC-3, a human prostate cancer cell line. Urol Oncol. 2002 Nov-Dec; 7(6):229-34.
Score: 0.032
-
IFN gamma-induced up-regulation of PD-ECGF/TP enhances the cytotoxicity of 5-fluorouracil and 5'-deoxy-5-fluorouridine in bladder cancer cells. Anticancer Res. 2002 Sep-Oct; 22(5):2607-12.
Score: 0.032
-
[Acute promyelocytic leukemia complicated with central nervous system involvement successfully treated with all-trans retinoic acid via nasogastric tube]. Rinsho Ketsueki. 2022; 63(1):26-30.
Score: 0.030
-
Early central nervous system relapse of monomorphic epitheliotropic intestinal T-cell lymphoma after cord blood transplantation. Int J Hematol. 2021 Jul; 114(1):129-135.
Score: 0.028
-
Advanced testicular germ cell tumor in a hemophilic patient with human immunodeficiency virus infection. Jpn J Clin Oncol. 1998 Sep; 28(9):567-70.
Score: 0.024
-
[High dose chemotherapy with peripheral blood stem cell transplantation (PBSCT) For advanced testicular cancer]. Hinyokika Kiyo. 1998 May; 44(5):313-8.
Score: 0.023
-
[Valacyclovir Maintenance Therapy for a Case of Unilateral Acute Retinal Necrosis during Chemotherapy]. Kansenshogaku Zasshi. 2017 Mar; 91(2):159-62.
Score: 0.022
-
[Superior sagittal sinus thrombosis after intrathecal chemotherapy and intravenous high-dose cytarabine in an acute myeloid leukemia case with t(8;21)(q22;q22)]. Rinsho Ketsueki. 2016 Apr; 57(4):477-82.
Score: 0.020
-
Late relapse of stage I testicular seminoma metastatic to just a para-ureteropelvic region. Int J Urol. 2004 Nov; 11(11):1044-6.
Score: 0.009
-
Successful long-term disease-free survival following multimodal treatments in a patient with a repeatedly recurrent refractory adrenal cortical carcinoma. Int J Urol. 2003 Aug; 10(8):445-8.
Score: 0.008
-
[Experience with induction chemoradiotherapy for cT4N2M0 lung cancer]. Kyobu Geka. 2000 Mar; 53(3):239-41.
Score: 0.007
-
Late recurrence and progression after a long tumor-free period in primary Ta and T1 bladder cancer. Eur Urol. 1999 Oct; 36(4):309-13.
Score: 0.006